(Reuters) - German molecular testing company Qiagen NV (QIA.DE) said on Tuesday it has begun shipping its diagnostic test for COVID-19 to the United States.
The test kit, QIAstat-Dx Respiratory SARS-CoV-2 Panel, requires less than one minute for sample preparation and can deliver results in about one hour, the company said.
Shipments come under a new policy laid out by the U.S. Food and Drug Administration earlier this month to help accelerate the availability of coronavirus diagnostic tests, developed by laboratories and commercial manufacturers during the public health emergency.